Drw Securities, LLC Immunity Bio, Inc. Transaction History
Drw Securities, LLC
- $4.42 Billion
- Q3 2025
A detailed history of Drw Securities, LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Drw Securities, LLC holds 142,388 shares of IBRX stock, worth $296,167. This represents 0.01% of its overall portfolio holdings.
Number of Shares
142,388Holding current value
$296,167% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding IBRX
# of Institutions
297Shares Held
152MCall Options Held
3.11MPut Options Held
3.29M-
Vanguard Group Inc Valley Forge, PA27.7MShares$57.5 Million0.0% of portfolio
-
Jane Street Group, LLC New York, NY12.8MShares$26.7 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$23.8 Million0.0% of portfolio
-
State Street Corp Boston, MA11.3MShares$23.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.89MShares$14.3 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $833M
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...